JP2016517849A5 - - Google Patents

Download PDF

Info

Publication number
JP2016517849A5
JP2016517849A5 JP2016507969A JP2016507969A JP2016517849A5 JP 2016517849 A5 JP2016517849 A5 JP 2016517849A5 JP 2016507969 A JP2016507969 A JP 2016507969A JP 2016507969 A JP2016507969 A JP 2016507969A JP 2016517849 A5 JP2016517849 A5 JP 2016517849A5
Authority
JP
Japan
Prior art keywords
compound
substituent
formula
carbon atoms
ethylpyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016507969A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016517849A (ja
JP6356218B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2013/074363 external-priority patent/WO2014169462A1/zh
Publication of JP2016517849A publication Critical patent/JP2016517849A/ja
Publication of JP2016517849A5 publication Critical patent/JP2016517849A5/ja
Application granted granted Critical
Publication of JP6356218B2 publication Critical patent/JP6356218B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016507969A 2013-04-18 2013-04-18 抗腫瘍活性を有する7−α−[9−(4,4,5,5,5−ペンタフルオロペンチルスルフィニル)ノニル]−エストラ−1,3,5(10)−トリエン−3,17β−ジオールのエステル誘導体及びその調製方法 Expired - Fee Related JP6356218B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2013/074363 WO2014169462A1 (zh) 2013-04-18 2013-04-18 具有抗癌活性的7-α-[9-(4,4,5,5,-五氟戊基亚硫酰基)壬基]-雌甾-1,3,5(10)-三烯-3,17β-二醇的酯类衍生物及其制备方法

Publications (3)

Publication Number Publication Date
JP2016517849A JP2016517849A (ja) 2016-06-20
JP2016517849A5 true JP2016517849A5 (https=) 2017-03-09
JP6356218B2 JP6356218B2 (ja) 2018-07-11

Family

ID=51730699

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016507969A Expired - Fee Related JP6356218B2 (ja) 2013-04-18 2013-04-18 抗腫瘍活性を有する7−α−[9−(4,4,5,5,5−ペンタフルオロペンチルスルフィニル)ノニル]−エストラ−1,3,5(10)−トリエン−3,17β−ジオールのエステル誘導体及びその調製方法

Country Status (8)

Country Link
US (1) US20160060288A1 (https=)
EP (1) EP2987799B1 (https=)
JP (1) JP6356218B2 (https=)
KR (1) KR102046415B1 (https=)
CN (1) CN104936971B (https=)
AU (1) AU2013386732B2 (https=)
CA (1) CA2909418A1 (https=)
WO (1) WO2014169462A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014169456A1 (zh) * 2013-04-18 2014-10-23 西安力邦医药科技有限责任公司 7-α-[9-(4,4,5,5,5-五氟戊基亚硫酰基)壬基]-雌甾-1,3,5(10)-三烯-3,17β-二醇及其衍生物的用途
JP7384903B2 (ja) * 2018-05-24 2023-11-21 ケーアイ ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー フルベストラントのプロドラッグ
EP4061376A4 (en) * 2019-11-24 2024-03-13 Kashiv Biosciences, LLC Prodrugs of fulvestrant

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7613248A (nl) * 1976-11-26 1978-05-30 Akzo Nv Werkwijze voor het bereiden van nieuwe steroid- esters.
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
US5183514A (en) 1991-04-01 1993-02-02 Texaco Chemical Company Process for dissolving or removing rigid polyurethane foam by contacting with 1,2-dimethyl imidazole
DE4218743C2 (de) * 1992-06-04 2001-10-25 Schering Ag Verfahren zur Herstellung C(7)-substituierter Estra-1,3,5(10)-triene sowie neue Ausgangsprodukte für dieses Verfahren
IL112778A0 (en) * 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
DE19635525A1 (de) * 1996-08-20 1998-02-26 Schering Ag 7alpha-(xi-Aminoalkyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha(xi-Aminoalkyl-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
AR015500A1 (es) * 1997-12-23 2001-05-02 Schering Ag 11 BETA-HALoGENO-ESTRATRIENOS SUSTITUIDOS EN 7 ALFA, PROCEDIMIENTO PARA ELABORAR PREPARADOS FARMACEUTICOS QUE CONTIENEN TALES 11 BETA-HALOGENO-ESTRATRIENOSSUSTITUIDOS EN 7 ALFA, ASI COMO SU UTILIZACION EN LA ELABORACION DE MEDICAMENTOS.
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
JP2005524630A (ja) * 2002-01-14 2005-08-18 ノルディック・ビオサイエンス・エー/エス エストロゲン受容体を介する軟骨破壊の抑制
CN100395259C (zh) * 2004-04-28 2008-06-18 江苏豪森药业股份有限公司 甾体类衍生物
US7790910B2 (en) * 2004-07-27 2010-09-07 Sicor Inc. Process for the preparation of 7α-alkylated 19-norsteroids
US10174070B2 (en) * 2005-09-30 2019-01-08 Endece Llc 6-substituted estradiol derivatives and methods of use
JP5256042B2 (ja) * 2005-11-22 2013-08-07 インサイト・コーポレイション 癌の処置のための併用療法
JP2011514349A (ja) * 2008-03-07 2011-05-06 サイドース・エルエルシー フルベストラント配合物
CN102600073B (zh) * 2012-03-31 2014-01-01 莱普德制药有限公司 以乳酸酯为基础的氟维司群或其衍生物油性制剂及其制备方法
WO2014169456A1 (zh) * 2013-04-18 2014-10-23 西安力邦医药科技有限责任公司 7-α-[9-(4,4,5,5,5-五氟戊基亚硫酰基)壬基]-雌甾-1,3,5(10)-三烯-3,17β-二醇及其衍生物的用途
US9271990B2 (en) * 2014-02-14 2016-03-01 Fresenius Kabi Usa, Llc Fulvestrant formulations

Similar Documents

Publication Publication Date Title
CN106061990B (zh) 一种阿比特龙衍生物及其制备方法和医药用途
CN103619867B (zh) 用于产生雌四醇中间体的方法
JP2013533291A5 (https=)
CN105377871B (zh) 阿比特龙及其中间体的制备方法
CA2871314A1 (en) Process for preparation of 17-substituted steroids
JP2015531392A5 (https=)
JP2016517849A5 (https=)
JP2022541298A (ja) スピロ(3,3’-イソプロピルピロリジンオキシインドール)系肝臓x受容体モジュレーター及びその調製方法と応用
CN103772277B (zh) 羟氯喹亚麻酸酯及其合成方法
CN110804082B (zh) 一种胆酸类衍生物及其制备方法和应用
JP2017514865A5 (https=)
CN102558282B (zh) 一种熊果酸衍生物及其制备方法
JP3839813B2 (ja) カンプトテシン誘導体の調製に有用な化合物
JP6356218B2 (ja) 抗腫瘍活性を有する7−α−[9−(4,4,5,5,5−ペンタフルオロペンチルスルフィニル)ノニル]−エストラ−1,3,5(10)−トリエン−3,17β−ジオールのエステル誘導体及びその調製方法
WO2015014686A1 (en) Process for the preparation of abiraterone or abiraterone acetate
CN117924404A (zh) 一种基于雷公藤红素的protac化合物、制备方法及应用
WO2014188445A1 (en) PROCESS FOR THE PREPARATION OF (3β)-17-(3-PYRIDINYL)ANDROSTA-5,16-DIEN-3-YL ACETATE AND POLYMORPH THEREOF
CN103509079B (zh) 一种熊果酸衍生物及其制备方法
Bian et al. Green Suzuki coupling reaction for synthesis of abiraterone acetate and its analogues
KR20160075508A (ko) 마크로락탐을 제조하기 위한 방법 및 중간체
CN106432043B (zh) 2,3-吲哚二酮-3-n-烯基硝酮衍生物及其合成方法和应用
CN102627682A (zh) 酯化、卤代豆甾醇衍生物及其在抗癌药物中的应用
CN103145719B (zh) 灵菌红素衍生物的制备方法
CN110669097B (zh) 一种齐墩果烯衍生物的合成方法
CZ2014475A3 (cs) Způsob přípravy Abirateron acetátu o vysoké čistotě aplikovatelný v průmyslovém měřítku